Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments

Fig. 4

Percentages of circulating endothelial cells (CEC), endothelial progenitor cells (EPC) and circulating fibrocytes in patients with idiopathic pulmonary fibrosis treated with different therapies. Bar plots with error bars (mean + standard error of the mean) indicating (a) the percentage of CEC; (b) the amount of CD309 among CEC; (c) the percentage of EPC; (d) the percentage of EPC expressing CD309; (e) circulating collagen I+ cells; (f) the amount of CXCR4 among fibrocytes in untreated patients (UNTR) and in patients treated with pirfenidone (PIR) or nintedanib (NIN). P-values, calculated using a Kruskal–Wallis test, only significant values are displayed

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us